Last 12 months
Inside the activity.
0 purchase rows · 76 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 19 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 11 |
| Mar 2026 | 0 | 13 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 8 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 10 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 12, 2020 Filed Nov 13, 2020 16:57 UTC |
Welgus Howard G.Director
|
Exercise / conversionCommon Stock | 1,222 | $0.58 | $709.00 |
DisclosureSEC source: 0001567619-20-019438 · doc1.xml · nonDerivative · entry 1 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,844 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 21:34 UTC |
Curran TerrieDirector
|
GrantStock Option (Right to Buy) · Derivative | 37,500 | $0.00 Strike: $18.72 | $0.00 |
DisclosureSEC source: 0001567619-20-018694 · doc1.xml · derivative · entry 1 Curran Terrie · CIK 0001690298 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires 2030-11-02 F1 · derivative.exercise_date: The option vests as to 1/3 of the total shares on each of November 2, 2021, November 2, 2022 and November 2, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 21:33 UTC |
Welgus Howard G.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,809 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001567619-20-018692 · doc1.xml · derivative · entry 6 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,772 Underlying: Common Stock · 1,809 shares Expires 2029-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F4 · derivative.exercise_date: The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 21:33 UTC |
Welgus Howard G.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 391 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001567619-20-018692 · doc1.xml · derivative · entry 5 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,057 Underlying: Common Stock · 391 shares Expires 2029-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F4 · derivative.exercise_date: The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 21:33 UTC |
Welgus Howard G.Director
|
SaleCommon Stock | 2,200 | $18.27 | $40,186.08 |
DisclosureSEC source: 0001567619-20-018692 · doc1.xml · nonDerivative · entry 3 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,622 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $18.02 to $18.63, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 21:33 UTC |
Welgus Howard G.Director
|
Exercise / conversionCommon Stock | 1,809 | $1.68 | $3,039.12 |
DisclosureSEC source: 0001567619-20-018692 · doc1.xml · nonDerivative · entry 2 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,822 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 21:33 UTC |
Welgus Howard G.Director
|
Exercise / conversionCommon Stock | 391 | $1.68 | $656.88 |
DisclosureSEC source: 0001567619-20-018692 · doc1.xml · nonDerivative · entry 1 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,013 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| October 26, 2020 Filed Oct 27, 2020 18:03 UTC |
Lock Kenneth A.Chief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,668 | $0.00 Strike: $6.52 | $0.00 |
DisclosureSEC source: 0001567619-20-018207 · doc1.xml · derivative · entry 2 Lock Kenneth A. · CIK 0001801047 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,080 Underlying: Common Stock · 2,668 shares Expires 2029-10-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares. F3 · derivative.exercise_date: The option began vesting as to 1/4 of the total shares on October 14, 2020, and then 1/48 of the total shares vest monthly thereafter, with 100% of the total shares vested and exercisable on October 14, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. Read SEC document |
| October 26, 2020 Filed Oct 27, 2020 18:03 UTC |
Lock Kenneth A.Chief Commercial Officer
|
Exercise / conversionCommon Stock | 2,668 | $6.52 | $17,395.36 |
DisclosureSEC source: 0001567619-20-018207 · doc1.xml · nonDerivative · entry 1 Lock Kenneth A. · CIK 0001801047 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,863 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares. F2 · balance_after: Includes 9,000 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| October 22, 2020 Filed Oct 23, 2020 17:27 UTC |
Lock Kenneth A.Chief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,695 | $0.00 Strike: $6.52 | $0.00 |
DisclosureSEC source: 0001567619-20-018132 · doc1.xml · derivative · entry 2 Lock Kenneth A. · CIK 0001801047 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,748 Underlying: Common Stock · 2,695 shares Expires 2029-10-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares. F3 · derivative.exercise_date: The option began vesting as to 1/4 of the total shares on October 14, 2020, and then 1/48 of the total shares vest monthly thereafter, with 100% of the total shares vested and exercisable on October 14, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. Read SEC document |
| October 22, 2020 Filed Oct 23, 2020 17:27 UTC |
Lock Kenneth A.Chief Commercial Officer
|
Exercise / conversionCommon Stock | 2,695 | $6.52 | $17,571.40 |
DisclosureSEC source: 0001567619-20-018132 · doc1.xml · nonDerivative · entry 1 Lock Kenneth A. · CIK 0001801047 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,195 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares. F2 · balance_after: Includes 9,000 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| October 15, 2020 Filed Oct 16, 2020 18:06 UTC |
Lock Kenneth A.Chief Commercial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $6.52 | $0.00 |
DisclosureSEC source: 0001567619-20-017916 · doc1.xml · derivative · entry 2 Lock Kenneth A. · CIK 0001801047 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,443 Underlying: Common Stock · 7,500 shares Expires 2029-10-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares. F3 · derivative.exercise_date: The option began vesting as to 1/4 of the total shares on October 14, 2020, and then 1/48 of the total shares vest monthly thereafter, with 100% of the total shares vested and exercisable on October 14, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. Read SEC document |
| October 15, 2020 Filed Oct 16, 2020 18:06 UTC |
Lock Kenneth A.Chief Commercial Officer
|
Exercise / conversionCommon Stock | 7,500 | $6.52 | $48,900.00 |
DisclosureSEC source: 0001567619-20-017916 · doc1.xml · nonDerivative · entry 1 Lock Kenneth A. · CIK 0001801047 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares. F2 · balance_after: Includes 9,000 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| October 15, 2020 Filed Oct 16, 2020 18:06 UTC |
Welgus Howard G.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,222 | $0.00 Strike: $0.58 | $0.00 |
DisclosureSEC source: 0001567619-20-017915 · doc1.xml · derivative · entry 3 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,106 Underlying: Common Stock · 1,222 shares Expires 2028-06-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares. F3 · derivative.exercise_date: The option began vesting monthly over 35 months beginning July 11, 2019, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. Read SEC document |
| October 15, 2020 Filed Oct 16, 2020 18:06 UTC |
Welgus Howard G.Director
|
Exercise / conversionCommon Stock | 1,222 | $0.58 | $709.00 |
DisclosureSEC source: 0001567619-20-017915 · doc1.xml · nonDerivative · entry 1 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,622 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares. Read SEC document |
| October 02, 2020 Filed Oct 6, 2020 21:27 UTC |
ORBIMED ADVISORS LLCDirector · 10% owner
ORBIMED CAPITAL LLCDirector · 10% owner
OrbiMed Capital GP VII LLCDirector · 10% owner
|
PurchaseCommon Stock | 296,000 | $25.00 | $7,400,000.00 |
DisclosureSEC source: 0000947871-20-000782 · ownership.xml · nonDerivative · entry 2 ORBIMED ADVISORS LLC · CIK 0001055951 · Director · 10% owner ORBIMED CAPITAL LLC · CIK 0001157524 · Director · 10% owner OrbiMed Capital GP VII LLC · CIK 0001760648 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 902,286 F1 · shares: These shares of the Issuer's common stock ("Shares") were purchased in a private placement exempt from the registration requirements of the Securities Act of 1933, as amended. F3 · ownership.nature: This report on Form 4 is filed by OrbiMed Advisors, OrbiMed GP VII, and OrbiMed Capital LLC ("OrbiMed Capital"). Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. This report on Form 4 shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. The Reporting Persons have designated Jonathan Silverstein to serve on the Issuer's board of directors. F4 · ownership.nature: The Shares are held of record by OrbiMed Partners Master Fund Limited ("OPM"). OrbiMed Capital is the investment manager of OPM and is a relying advisor of OrbiMed Advisors. OrbiMed Advisors and OrbiMed Capital exercise voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and Jonathan T. Silverstein, each of whom disclaims beneficial ownership of the Shares held by OPM. Read SEC document |
| October 02, 2020 Filed Oct 6, 2020 21:27 UTC |
ORBIMED ADVISORS LLCDirector · 10% owner
ORBIMED CAPITAL LLCDirector · 10% owner
OrbiMed Capital GP VII LLCDirector · 10% owner
|
PurchaseCommon Stock | 200,000 | $25.00 | $5,000,000.00 |
DisclosureSEC source: 0000947871-20-000782 · ownership.xml · nonDerivative · entry 1 ORBIMED ADVISORS LLC · CIK 0001055951 · Director · 10% owner ORBIMED CAPITAL LLC · CIK 0001157524 · Director · 10% owner OrbiMed Capital GP VII LLC · CIK 0001760648 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 4,267,564 F1 · shares: These shares of the Issuer's common stock ("Shares") were purchased in a private placement exempt from the registration requirements of the Securities Act of 1933, as amended. F2 · ownership.nature: The Shares are held of record by OrbiMed Private Investments VII, LP ("OPI VII"). OrbiMed Capital GP VII LLC ("OrbiMed GP VII") is the general partner of OPI VII and OrbiMed Advisors LLC ("OrbiMed Advisors") is the managing member of OrbiMed GP VII. OrbiMed GP VII and OrbiMed Advisors may be deemed to have voting and investment power over the securities held by OPI VII and may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and Jonathan T. Silverstein, each of whom disclaims beneficial ownership of the Shares held by OPI VII. F3 · ownership.nature: This report on Form 4 is filed by OrbiMed Advisors, OrbiMed GP VII, and OrbiMed Capital LLC ("OrbiMed Capital"). Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. This report on Form 4 shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. The Reporting Persons have designated Jonathan Silverstein to serve on the Issuer's board of directors. Read SEC document |
| October 02, 2020 Filed Oct 6, 2020 17:23 UTC |
SILVERSTEIN JONATHANDirector · 10% owner
|
PurchaseCommon Stock | 296,000 | $25.00 | $7,400,000.00 |
DisclosureSEC source: 0000947871-20-000781 · ownership.xml · nonDerivative · entry 2 SILVERSTEIN JONATHAN · CIK 0001171005 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 902,286 F1 · shares: These shares of the Issuer's common stock ("Shares") were purchased in a private placement exempt from the registration requirements of the Securities Act of 1933, as amended. F3 · ownership.nature: The Reporting Person is the designated representative of OrbiMed Advisors, OrbiMed GP VII, and OrbiMed Capital LLC ("OrbiMed Capital") on the Issuer's board of directors. Each of OrbiMed GP VII, OrbiMed Advisors, OrbiMed Capital LLC, and the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report on Form 4 shall not be deemed an admission that any such entity or person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. F4 · ownership.nature: The Shares are held of record by OrbiMed Partners Master Fund Limited ("OPM"). OrbiMed Capital is the investment manager of OPM and is a relying adviser of OrbiMed Advisors. OrbiMed Advisors and OrbiMed Capital exercise voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and the Reporting Person, each of whom disclaims beneficial ownership of the Shares held by OPM. Read SEC document |
| October 02, 2020 Filed Oct 6, 2020 17:23 UTC |
SILVERSTEIN JONATHANDirector · 10% owner
|
PurchaseCommon Stock | 200,000 | $25.00 | $5,000,000.00 |
DisclosureSEC source: 0000947871-20-000781 · ownership.xml · nonDerivative · entry 1 SILVERSTEIN JONATHAN · CIK 0001171005 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 4,267,564 F1 · shares: These shares of the Issuer's common stock ("Shares") were purchased in a private placement exempt from the registration requirements of the Securities Act of 1933, as amended. F2 · ownership.nature: The Shares are held of record by OrbiMed Private Investments VII, LP ("OPI VII"). OrbiMed Capital GP VII LLC ("OrbiMed GP VII"), is the general partner of OPI VII and OrbiMed Advisors LLC ("OrbiMed Advisors") is the managing member of OrbiMed GP VII. OrbiMed GP VII and OrbiMed Advisors may be deemed to have voting and investment power over the securities held by OPI VII and may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and the Reporting Person, each of whom disclaims beneficial ownership of the Shares held by OPI VII. F3 · ownership.nature: The Reporting Person is the designated representative of OrbiMed Advisors, OrbiMed GP VII, and OrbiMed Capital LLC ("OrbiMed Capital") on the Issuer's board of directors. Each of OrbiMed GP VII, OrbiMed Advisors, OrbiMed Capital LLC, and the Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report on Form 4 shall not be deemed an admission that any such entity or person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| October 01, 2020 Filed Oct 6, 2020 01:13 UTC |
Welgus Howard G.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 390 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001567619-20-017606 · doc1.xml · derivative · entry 7 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,448 Underlying: Common Stock · 390 shares Expires 2029-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F4 · derivative.exercise_date: The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. Read SEC document |
| October 01, 2020 Filed Oct 6, 2020 01:13 UTC |
Welgus Howard G.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,810 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001567619-20-017606 · doc1.xml · derivative · entry 6 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,581 Underlying: Common Stock · 1,810 shares Expires 2029-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F4 · derivative.exercise_date: The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. Read SEC document |
| October 01, 2020 Filed Oct 6, 2020 01:13 UTC |
Welgus Howard G.Director
|
SaleCommon Stock | 390 | $25.18 | $9,820.71 |
DisclosureSEC source: 0001567619-20-017606 · doc1.xml · nonDerivative · entry 4 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,400 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $27.68 to $28.46, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| October 01, 2020 Filed Oct 6, 2020 01:13 UTC |
Welgus Howard G.Director
|
Exercise / conversionCommon Stock | 390 | $1.68 | $655.20 |
DisclosureSEC source: 0001567619-20-017606 · doc1.xml · nonDerivative · entry 3 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,790 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| October 01, 2020 Filed Oct 6, 2020 01:13 UTC |
Welgus Howard G.Director
|
SaleCommon Stock | 1,810 | $28.18 | $51,008.15 |
DisclosureSEC source: 0001567619-20-017606 · doc1.xml · nonDerivative · entry 2 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,400 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $27.68 to $28.46, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| October 01, 2020 Filed Oct 6, 2020 01:13 UTC |
Welgus Howard G.Director
|
Exercise / conversionCommon Stock | 1,810 | $1.68 | $3,040.80 |
DisclosureSEC source: 0001567619-20-017606 · doc1.xml · nonDerivative · entry 1 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,210 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| September 29, 2020 Filed Oct 1, 2020 21:01 UTC |
OSBORNE DAVID WChief Technical Officer
|
SaleCommon Stock | 15,000 | $30.00 | $450,000.00 |
DisclosureSEC source: 0001567619-20-017382 · doc1.xml · nonDerivative · entry 1 OSBORNE DAVID W · CIK 0001252999 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,279 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: Includes 9,000 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| September 29, 2020 Filed Oct 2, 2020 01:00 UTC |
Smither John WChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 500 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001567619-20-017381 · doc1.xml · derivative · entry 4 Smither John W · CIK 0001559583 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,482 Underlying: Common Stock · 500 shares Expires 2029-05-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F4 · derivative.exercise_date: The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. Read SEC document |
| September 29, 2020 Filed Oct 2, 2020 01:00 UTC |
Smither John WChief Financial Officer
|
SaleCommon Stock | 1,250 | $30.00 | $37,500.00 |
DisclosureSEC source: 0001567619-20-017381 · doc1.xml · nonDerivative · entry 3 Smither John W · CIK 0001559583 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 98,715 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F3 · ownership.nature: The securities are held of record by The 1994 Smither Family Trust, as Amended and Restated in 2014, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| September 29, 2020 Filed Oct 2, 2020 01:00 UTC |
Smither John WChief Financial Officer
|
SaleCommon Stock | 500 | $30.00 | $15,000.00 |
DisclosureSEC source: 0001567619-20-017381 · doc1.xml · nonDerivative · entry 2 Smither John W · CIK 0001559583 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,875 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: Includes 9,000 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| September 29, 2020 Filed Oct 2, 2020 01:00 UTC |
Smither John WChief Financial Officer
|
Exercise / conversionCommon Stock | 500 | $1.68 | $840.30 |
DisclosureSEC source: 0001567619-20-017381 · doc1.xml · nonDerivative · entry 1 Smither John W · CIK 0001559583 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: Includes 9,000 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof. Read SEC document |
| September 29, 2020 Filed Oct 2, 2020 01:02 UTC |
Watanabe ToddDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001567619-20-017383 · doc1.xml · derivative · entry 7 Watanabe Todd Franklin · CIK 0001801061 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,492 Underlying: Common Stock · 3,000 shares Expires 2029-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F6 · derivative.exercise_date: The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. Read SEC document |
| September 29, 2020 Filed Oct 2, 2020 01:02 UTC |
Watanabe ToddDirector · President and CEO
|
SaleCommon Stock | 3,000 | $30.00 | $90,000.00 |
DisclosureSEC source: 0001567619-20-017383 · doc1.xml · nonDerivative · entry 2 Watanabe Todd Franklin · CIK 0001801061 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 566,928 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| September 29, 2020 Filed Oct 2, 2020 01:02 UTC |
Watanabe ToddDirector · President and CEO
|
Exercise / conversionCommon Stock | 3,000 | $1.68 | $5,041.80 |
DisclosureSEC source: 0001567619-20-017383 · doc1.xml · nonDerivative · entry 1 Watanabe Todd Franklin · CIK 0001801061 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 569,928 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| September 29, 2020 Filed Jan 7, 2021 19:39 UTC |
Watanabe ToddDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001567619-21-000711 · doc1.xml · derivative · entry 7 Watanabe Todd Franklin · CIK 0001801061 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,492 Underlying: Common Stock · 3,000 shares Expires 2029-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F6 · derivative.exercise_date: The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. Read SEC document |
| September 29, 2020 Filed Jan 7, 2021 19:39 UTC |
Watanabe ToddDirector · President and CEO
|
SaleCommon Stock | 3,000 | $30.00 | $90,000.00 |
DisclosureSEC source: 0001567619-21-000711 · doc1.xml · nonDerivative · entry 2 Watanabe Todd Franklin · CIK 0001801061 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 566,928 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| September 29, 2020 Filed Jan 7, 2021 19:39 UTC |
Watanabe ToddDirector · President and CEO
|
Exercise / conversionCommon Stock | 3,000 | $1.68 | $5,041.80 |
DisclosureSEC source: 0001567619-21-000711 · doc1.xml · nonDerivative · entry 1 Watanabe Todd Franklin · CIK 0001801061 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 569,928 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| September 15, 2020 Filed Sep 16, 2020 21:57 UTC |
Welgus Howard G.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,222 | $0.00 Strike: $0.58 | $0.00 |
DisclosureSEC source: 0001567619-20-016809 · doc1.xml · derivative · entry 3 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,328 Underlying: Common Stock · 1,222 shares Expires 2028-06-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares. F3 · derivative.exercise_date: The option began vesting monthly over 35 months beginning July 11, 2019, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. Read SEC document |
| September 15, 2020 Filed Sep 16, 2020 21:57 UTC |
Welgus Howard G.Director
|
Exercise / conversionCommon Stock | 1,222 | $0.58 | $709.00 |
DisclosureSEC source: 0001567619-20-016809 · doc1.xml · nonDerivative · entry 1 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 15:48 UTC |
Welgus Howard G.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,200 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001567619-20-016301 · doc1.xml · derivative · entry 4 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,810 Underlying: Common Stock · 2,200 shares Expires 2029-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F4 · derivative.exercise_date: The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 15:48 UTC |
Welgus Howard G.Director
|
SaleCommon Stock | 2,200 | $24.38 | $53,643.26 |
DisclosureSEC source: 0001567619-20-016301 · doc1.xml · nonDerivative · entry 2 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,178 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $24.00 to $25.00, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 15:48 UTC |
Welgus Howard G.Director
|
Exercise / conversionCommon Stock | 2,200 | $1.68 | $3,696.00 |
DisclosureSEC source: 0001567619-20-016301 · doc1.xml · nonDerivative · entry 1 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,378 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| September 01, 2020 Filed Oct 6, 2020 01:12 UTC Amendment |
Welgus Howard G.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,172 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001567619-20-017605 · doc1.xml · derivative · entry 7 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,838 Underlying: Common Stock · 1,172 shares Expires 2029-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F4 · derivative.exercise_date: The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. Read SEC document |
| September 01, 2020 Filed Oct 6, 2020 01:12 UTC Amendment |
Welgus Howard G.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,028 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001567619-20-017605 · doc1.xml · derivative · entry 6 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,391 Underlying: Common Stock · 1,028 shares Expires 2029-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F4 · derivative.exercise_date: The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. Read SEC document |
| September 01, 2020 Filed Oct 6, 2020 01:12 UTC Amendment |
Welgus Howard G.Director
|
SaleCommon Stock | 1,172 | $24.38 | $28,577.23 |
DisclosureSEC source: 0001567619-20-017605 · doc1.xml · nonDerivative · entry 4 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,178 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $24.00 to $25.00, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| September 01, 2020 Filed Oct 6, 2020 01:12 UTC Amendment |
Welgus Howard G.Director
|
Exercise / conversionCommon Stock | 1,172 | $1.68 | $1,968.96 |
DisclosureSEC source: 0001567619-20-017605 · doc1.xml · nonDerivative · entry 3 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,350 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| September 01, 2020 Filed Oct 6, 2020 01:12 UTC Amendment |
Welgus Howard G.Director
|
SaleCommon Stock | 1,028 | $24.38 | $25,066.03 |
DisclosureSEC source: 0001567619-20-017605 · doc1.xml · nonDerivative · entry 2 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,178 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The transaction was executed in multiple trades in prices ranging from $24.00 to $25.00, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| September 01, 2020 Filed Oct 6, 2020 01:12 UTC Amendment |
Welgus Howard G.Director
|
Exercise / conversionCommon Stock | 1,028 | $1.68 | $1,727.04 |
DisclosureSEC source: 0001567619-20-017605 · doc1.xml · nonDerivative · entry 1 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,206 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| August 20, 2020 Filed Aug 21, 2020 18:19 UTC |
Welgus Howard G.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001567619-20-015854 · doc1.xml · derivative · entry 3 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,982 Underlying: Common Stock · 5,000 shares Expires 2029-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares. F3 · derivative.exercise_date: The option began vesting on March 13, 2019 and will vest monthly over a four year period, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. Read SEC document |
| August 20, 2020 Filed Aug 21, 2020 18:19 UTC |
Welgus Howard G.Director
|
Exercise / conversionCommon Stock | 5,000 | $1.68 | $8,400.00 |
DisclosureSEC source: 0001567619-20-015854 · doc1.xml · nonDerivative · entry 1 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,178 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares. Read SEC document |
| August 18, 2020 Filed Aug 19, 2020 21:48 UTC |
Welgus Howard G.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,076 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001567619-20-015772 · doc1.xml · derivative · entry 3 Welgus Howard G. · CIK 0001801050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,667 Underlying: Common Stock · 5,076 shares Expires 2029-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares. F3 · derivative.exercise_date: The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.